secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001599298-24-000040
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics presents at Barclays conference; no new material disclosed in filing excerpt
--------------------------------------------------------------------------------

- Presentation slides made available on March 12, 2024 at Barclays Global Healthcare Conference.
- Speakers listed: Dr. Maky Zanganeh (CEO & President) and Bob Duggan (Chairman & CEO).
- No specific pipeline updates, financial data, or clinical results provided in the filed exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000040/0001599298-24-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000040/smmt-20240312.htm
  HTML page:      https://secwatch.observer/filing/0001599298-24-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer